Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments

Significance Numerous reports indicate that amyloid-β peptide (Aβ) oligomers, considered the pathogenic molecular form of Aβ in Alzheimer´s disease (AD), exert their neurotoxicity within the membrane. Therefore, it is critical to characterize them in such an environment. Here, we worked with two major Aβ variants and handled them as if they were membrane proteins. By doing so, we found that the Aβ variant most strongly linked to AD assembled into stable Aβ oligomers that adopted a specific structure and incorporated into membranes as pores, a feature linked to neurotoxicity. Having access to pore-forming Aβ oligomers with such a specific structure offers unique opportunities to fully characterize them and establish their involvement in AD. The formation of amyloid-β peptide (Aβ) oligomers at the cellular membrane is considered to be a crucial process underlying neurotoxicity in Alzheimer’s disease (AD). Therefore, it is critical to characterize the oligomers that form within a membrane environment. To contribute to this characterization, we have applied strategies widely used to examine the structure of membrane proteins to study the two major Aβ variants, Aβ40 and Aβ42. Accordingly, various types of detergent micelles were extensively screened to identify one that preserved the properties of Aβ in lipid environments—namely the formation of oligomers that function as pores. Remarkably, under the optimized detergent micelle conditions, Aβ40 and Aβ42 showed different behavior. Aβ40 aggregated into amyloid fibrils, whereas Aβ42 assembled into oligomers that inserted into lipid bilayers as well-defined pores and adopted a specific structure with characteristics of a β-barrel arrangement that we named β-barrel pore-forming Aβ42 oligomers (βPFOsAβ42). Because Aβ42, relative to Aβ40, has a more prominent role in AD, the higher propensity of Aβ42 to form βPFOs constitutes an indication of their relevance in AD. Moreover, because βPFOsAβ42 adopt a specific structure, this property offers an unprecedented opportunity for testing a hypothesis regarding the involvement of βPFOs and, more generally, membrane-associated Aβ oligomers in AD.

[1]  Bappaditya Chandra,et al.  Cell-Membrane-Mimicking Lipid-Coated Nanoparticles Confer Raman Enhancement to Membrane Proteins and Reveal Membrane-Attached Amyloid-β Conformation. , 2015, ACS nano.

[2]  R. Nussinov,et al.  Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. , 2014, Chemical Society reviews.

[3]  M. de Maeyer,et al.  Tuning the size and properties of ClyA nanopores assisted by directed evolution. , 2013, Journal of the American Chemical Society.

[4]  L. Columbus,et al.  Solution NMR resonance assignment strategies for β‐barrel membrane proteins , 2013, Protein science : a publication of the Protein Society.

[5]  D. Otzen,et al.  Folding of outer membrane proteins. , 2013, Archives of biochemistry and biophysics.

[6]  D. Selkoe,et al.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[7]  Charles R. Sanders,et al.  The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol , 2012, Science.

[8]  S. Grage,et al.  Magnetically oriented dodecylphosphocholine bicelles for solid-state NMR structure analysis. , 2012, Biochimica et biophysica acta.

[9]  C. Borchers,et al.  Structure and dynamics of small soluble Aβ(1-40) oligomers studied by top-down hydrogen exchange mass spectrometry. , 2012, Biochemistry.

[10]  B. de Strooper,et al.  The mechanism of γ-Secretase dysfunction in familial Alzheimer disease , 2012, The EMBO journal.

[11]  David Eisenberg,et al.  Atomic View of a Toxic Amyloid Small Oligomer , 2012, Science.

[12]  Cees Dekker,et al.  Modeling the conductance and DNA blockade of solid-state nanopores , 2011, Nanotechnology.

[13]  H. Guy,et al.  Models of membrane‐bound Alzheimer's Abeta peptide assemblies , 2010, Proteins.

[14]  J. Popot Amphipols, nanodiscs, and fluorinated surfactants: three nonconventional approaches to studying membrane proteins in aqueous solutions. , 2010, Annual review of biochemistry.

[15]  Adelene Y. L. Sim,et al.  Mixing and matching detergents for membrane protein NMR structure determination. , 2009, Journal of the American Chemical Society.

[16]  G. Zamponi Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[17]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[18]  P. Hajduk,et al.  Structural characterization of a soluble amyloid beta-peptide oligomer. , 2009, Biochemistry.

[19]  A. M. Stanley,et al.  β-Barrel Proteins That Reside in the Escherichia coli Outer Membrane in Vivo Demonstrate Varied Folding Behavior in Vitro* , 2008, Journal of Biological Chemistry.

[20]  Korvin F. A. Walter,et al.  Bilayer in small bicelles revealed by lipid-protein interactions using NMR spectroscopy. , 2008, Journal of the American Chemical Society.

[21]  Carol V Robinson,et al.  Micelles Protect Membrane Complexes from Solution to Vacuum , 2008, Science.

[22]  Y. Ishii,et al.  Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid , 2007, Nature Structural &Molecular Biology.

[23]  C. Sanders,et al.  Solution NMR of membrane proteins: practice and challenges , 2006, Magnetic resonance in chemistry : MRC.

[24]  P. Keller,et al.  Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease , 2005 .

[25]  J. Pettegrew,et al.  Alzheimer’s Disease: Soluble Oligomeric Aβ(1–40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies , 2004, Neurochemical Research.

[26]  R. Kayed,et al.  Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases* , 2004, Journal of Biological Chemistry.

[27]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  J. Kourie,et al.  Diversity of Amyloid β Protein Fragment [1–40]-Formed Channels , 2001, Cellular and Molecular Neurobiology.

[29]  T. Schulte-Herbrüggen,et al.  Clean TROSY: compensation for relaxation-induced artifacts. , 2000, Journal of magnetic resonance.

[30]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[31]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Rojas,et al.  Zn2+ interaction with Alzheimer amyloid beta protein calcium channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Kurt Wüthrich,et al.  Effective rotational correlation times of proteins from NMR relaxation interference. , 2006, Journal of magnetic resonance.

[35]  P. Keller,et al.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. , 2005, Journal of neurochemistry.

[36]  J. Kourie,et al.  Diversity of amyloid beta protein fragment [1-40]-formed channels. , 2001, Cellular and molecular neurobiology.

[37]  Y. Hirakura,et al.  Alzheimer Amyloid Aβ1-42 Channels : Effects of Solvent, pH, and Congo Red. , 1999 .

[38]  H. Shao,et al.  Solution Structures of Micelle-bound Amyloid b-( 1-40 ) and b-( 1-42 ) Peptides of Alzheimer ' s Disease , 1998 .

[39]  Sebastian Hiller,et al.  References and Notes Supporting Online Material Materials and Methods Figures S1 to S5 Table S1 References Solution Structure of the Integral Human Membrane Protein Vdac-1 in Detergent Micelles , 2022 .